The Enterprise Value as of December 2024 (TTM) for Enlivex Therapeutics Ltd. (ENLV) is 25.04M

According to Enlivex Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.04M. This represents a change of -44.95% compared to the average of 45.48M of the last 4 quarters.

Enlivex Therapeutics Ltd. (ENLV) Historical Enterprise Value (quarterly & annually)

How has ENLV Enterprise Value performed in the past?

The mean historical Enterprise Value of Enlivex Therapeutics Ltd. over the last ten years is 49.62M. The current 25.04M Enterprise Value has changed 4.95% with respect to the historical average. Over the past ten years (40 quarters), ENLV's Enterprise Value was at its highest in in the September 2019 quarter at 267.18M. The Enterprise Value was at its lowest in in the March 2019 quarter at -8131089.80.

Enlivex Therapeutics Ltd. (ENLV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enlivex Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enlivex Therapeutics Ltd. (ENLV) Average Enterprise Value

How has ENLV Enterprise Value performed in the past?

The current Enterprise Value of Enlivex Therapeutics Ltd. (ENLV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Enlivex Therapeutics Ltd. (ENLV) Enterprise Value vs. Peers

How is ENLV’s Enterprise Value compared to its peers?

Enlivex Therapeutics Ltd.’s Enterprise Value is less than Pluri Inc. (52.05M), less than BioLineRx Ltd. (44.85M), greater than Purple Biotech Ltd. (4.44M), greater than Aridis Pharmaceuticals, Inc. (4.81M), greater than Histogen Inc. (-4487565.00), less than PMV Pharmaceuticals, Inc. (40.53M), greater than Aptevo Therapeutics Inc. (-501422.00), less than Protalix BioTherapeutics, Inc. (108.61M), less than Corvus Pharmaceuticals, Inc. (310.53M), greater than Phio Pharmaceuticals Corp. (-3068516.00), greater than Rain Therapeutics Inc. (7.16M), less than CollPlant Biotechnologies Ltd. (27.97M), less than Keros Therapeutics, Inc. (165.48M), less than Merus N.V. (2.47B), less than Vericel Corporation (2.87B), less than Century Therapeutics, Inc. (89.16M), less than Aldeyra Therapeutics, Inc. (270.65M), less than Gamida Cell Ltd. (57.65M), less than Checkpoint Therapeutics, Inc. (170.50M),

Build a custom stock screener for Enlivex Therapeutics Ltd. (ENLV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enlivex Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enlivex Therapeutics Ltd. (ENLV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enlivex Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.